The biliary HCO3 - Umbrella: Experimental evidence revisited

Current Opinion in Gastroenterology

Volumn 28, Issue 3, 2012, Pages 253-257

  Beuers, Ulrich ^a   Maroni, Luca ^a   Elferink, Ronald O ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

bicarbonate umbrella; cystic fibrosis; nonanastomotic strictures; primary biliary cirrhosis; primary sclerosing cholangitis

Indexed keywords

ADENOSINE TRIPHOSPHATE; BICARBONATE; BILE ACID; CHLORIDE;

BILE DUCT INJURY; BILIARY TRACT FIBROSIS; GLYCOCALYX; HEPATOBILIARY SYSTEM; HUMAN; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

ANIMALS; BICARBONATES; BILE ACIDS AND SALTS; BILE DUCTS; BILIARY TRACT; CHLORIDE-BICARBONATE ANTIPORTERS; CHOLANGITIS, SCLEROSING; FIBROSIS; HUMANS; MICE;

EID: 84859908601     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328352aab2     Document Type: Review

References (33)

1. Beuers U, Hohenester S, Maillette de Buy Wenniger L, et al. The biliary HCO3 S umbrella. Hepatology 2010; 52:1489-1496.
2. Lleo A, Bowlus CL, Yang GX, et al. Biliary apotopes and antimitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology 2010; 52:987-998.
3. Rust C, Wild N, Bernt C, et al. Bile acid-induced apoptosis in hepatocytes is caspase-6-dependent. J Biol Chem 2009; 284:2908-2916.
4. Hohenester S, Wenniger LM, Paulusma CC, et al. A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes. Hepatology 2012; 55:173-183.
5. Rust C, Karnitz LM, Paya CV, et al. The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3- kinase-dependent survival signaling cascade. J Biol Chem 2000; 275:20210-20216. (Pubitemid 30441633)
6. Salas JT, Banales JM, Sarvide S, et al. Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology 2008; 134:1482-1493. (Pubitemid 351626951)
7. Uriarte I, Banales JM, Saez E, et al. Bicarbonate secretion of mouse cholangiocytes involves Na(R)-HCO(3)(-) cotransport in addition to Na(R)- independent Cl(-)/HCO(3)(-) exchange. Hepatology 2010; 51:891-902.
8. Boyer JL. Mechanisms of bile secretion and hepatic transport. In: Andreoli TE, Hoffman JF, Fanestil DD, Schultz SG, editors. Physiology of membrane disorders. New York: Plenum Publishing Corporation 1986. pp. 609-636.
9. Alpini G, Roberts S, Kuntz SM, et al. Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology 1996; 110:1636-1643. (Pubitemid 26134100)
10. Woo K, Sathe M, Kresge C, et al. Adenosine triphosphate release and purinergic (P2) receptor-mediated secretion in small and large mouse cholangiocytes. Hepatology 2010; 52:1819-1828.
11. Strazzabosco M, Fiorotto R, Melero S, et al. Differentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation. Hepatology 2009; 50:244-252.
12. Minagawa N, Nagata J, Shibao K, et al. Cyclic AMP regulates bicarbonate secretion in cholangiocytes through release of ATP into bile. Gastroenterology 2007; 133:1592-1602. (Pubitemid 350029742)
13. Shibao K, Hirata K, Robert ME, Nathanson MH. Loss of inositol 1,4,5- trisphosphate receptors from bile duct epithelia is a common event in cholestasis. Gastroenterology 2003; 125:1175-1187. (Pubitemid 37193463)
14. Cohn JA, Strong TV, Picciotto MR, et al. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology 1993; 105:1857-1864. (Pubitemid 24002805)
15. Dutta AK, Khimji AK, Kresge C, et al. Identification and functional characterization of TMEM16A, a Ca2R-activated Cl- channel activated by extracellular nucleotides, in biliary epithelium. J Biol Chem 2011; 286:766-776.
16. EASL. Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51:237-267.
17. Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 2006; 3:318-328. (Pubitemid 43842248)
18. Uriz M, Saez E, Prieto J, et al. Ursodeoxycholic acid is conjugated with taurine to promote secretin-stimulated biliary hydrocholeresis in the normal rat. PLoS One 2011; 6:e28717.
19. Hofmann AF, Zakko SF, Lira M, et al. Novel biotransformation and physiological properties of norursodeoxycholic acid in humans. Hepatology 2005; 42:1391-1398. (Pubitemid 43260042)
20. Fickert P, Wagner M, Marschall HU, et al. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 2006; 130:465-481. (Pubitemid 43202044)
21. Halilbasic E, Fiorotto R, Fickert P, et al. Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice. Hepatology 2009; 49:1972-1981.
22. Denk GU, Maitz S, Wimmer R, et al. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver. Hepatology 2010; 52:1758-1768.
23. Hofmann AF. Bile acids: trying to understand their chemistry and biology with the hope of helping patients. Hepatology 2009; 49:1403-1418.
24. Rodriguez-Ortigosa CM, Banales JM, Olivas I, et al. Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat. Hepatology 2010; 52:667-677.
25. Baghdasaryan A, Claudel T, Gumhold J, et al. Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO output. Hepatology 2011; 54:1303-1312.
26. Keitel V, Ullmer C, Haussinger D. The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes. Biol Chem 2010; 391:785-789.
27. Chen F, Shyu AB, Shneider BL. Hu antigen R and tristetraprolin: counter-regulators of rat apical sodium-dependent bile acid transporter by way of effects on messenger RNA stability. Hepatology 2011; 54:1371-1378.
28. Masyuk AI, Masyuk TV, Splinter PL, et al. Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2R and cAMP signaling. Gastroenterology 2006; 131:911-920. (Pubitemid 44307075)
29. Masyuk AI, Huang BQ, Ward CJ, et al. Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia. Am J Physiol Gastrointest Liver Physiol 2010; 299:G990-G999.
30. Medina JF, Martinez A, Vazquez JJ, Prieto J. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology 1997; 25:12-17. (Pubitemid 27014978)
31. Hov JR, Keitel V, Laerdahl JK, et al. Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis. PLoS One 2010; 5:e12403.
32. Fiorotto R, Scirpo R, Trauner M, et al. Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-kappaB-mediated inflammatory response in mice. Gastroenterology 2011; 141:1498-1508; 508 e1-e5.
33. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366:539-551.